InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Liu David Y, Directeur Scientifique. Insider active across 1 companies, notably Protagonist Therapeutics, Inc. In total, 5 filings have been logged. The latest transaction was disclosed on 28 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
€46,0152,119 shares@ €21.71530.0008% mcap75.6% of flow
Common Stock
SEC:0001104659-22-029519:0·
010,000 shares0
Common Stock
SEC:0001104659-22-024840:0·
010,000 shares0
Common Stock
SEC:0001104659-22-024840·
€7,43010,000 shares@ €0.7430.0001% mcap100.0% of flow
Common Stock
SEC:0001104659-21-107818·
€7,43010,000 shares@ €0.7430.0001% mcap12.2% of flow
Common Stock
SEC:0001104659-21-107818:0·
5 of 5 declarations
About Liu David Y
Liu David Y serves as the Chief Scientific Officer at Protagonist Therapeutics, Inc. He is responsible for leading scientific research and product development. His role is crucial for innovation and advancing the company's research goals.
